Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs.

Please use this identifier to cite or link to this item: http://ir.sinica.edu.tw/handle/201000000A/76248

Title:	Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs.
Authors:	Bavli, Y Winkler, I Chen, BM Roffler, S Cohen, R Szebeni, J Barenholz, Y
Issue Date:	2019-07
Relation:	Journal of controlled release : official journal of the Controlled Release Society 306, 138-148
URI:	http://ir.sinica.edu.tw/handle/201000000A/76248
ISSN:	http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=0168-3659&DestApp=JCR&RQ=IF_CAT_BOXPLOT
URL:	http://dx.doi.org/10.1016/j.jconrel.2019.06.007
Appears in Collections:	生物醫學科學研究所

Show full item record

Check